A sweeping April 2026 Executive Order is creating significant immigration opportunities for foreign nationals working in mental health and medical research across the United States.
The order, signed on April 18, 2026, and titled “Accelerating Medical Treatments for Serious Mental Illness,” directs federal agencies to speed up research, regulatory review, and patient access to promising mental health therapies.
For foreign professionals in these fields, the order provides direct policy support for pursuing an EB-2 National Interest Waiver, known as an NIW, petition for a green card.
The EB-2 NIW waives the standard job offer and PERM labor certification requirements when the proposed work is in the national interest, allowing applicants to self-petition without employer sponsorship.
When evaluating NIW petitions, USCIS considers whether the proposed work aligns with national priorities or areas of demonstrated government interest, and executive orders carry particular weight in that analysis.
The April 2026 order directs the Food and Drug Administration to prioritise the review of certain psychedelic drugs that have earned Breakthrough Therapy designation, a status that accelerates the regulatory approval pathway.
The order also opens patient access routes under the Right to Try Act, which allows eligible patients with life-threatening conditions to seek certain investigational treatments outside of clinical trials.
The Department of Health and Human Services will allocate at least $50 million to partner with state programmes advancing this research, with veterans named as a specific priority population.
Professionals do not need to work directly on psychedelic drug research to benefit from the order, as its broader federal interest in improving mental health at a national scale applies across a wide range of disciplines.
Researchers, clinicians, pharmacologists, and public health professionals fit most naturally within the scope of the order, but professionals from technology, data, and social services may also qualify if their work supports mental health care delivery.
Law firm Colombo and Hurd has already secured a number of EB-2 NIW approvals for professionals working in mental health and medical research, illustrating the range of qualifying roles.
In one approved case, a mental health counsellor with over two decades of experience developed a trauma-responsive counselling model paired with career readiness programming, reaching hundreds of adolescents and producing measurable outcomes including higher school re-enrolment rates.
A clinical social worker received approval in five months and eight days after demonstrating her work addressed systemic healthcare disparities affecting diverse and underserved populations across the country.
A school psychologist who spent more than 15 years designing psycho-educational programmes for students with disabilities received approval in less than three months, with her petition linked to federal protections under the Americans with Disabilities Act.
Petitioners must demonstrate that their proposed endeavour has both substantial merit and national importance, and a current executive order directly referencing a field represents strong supporting evidence for that standard.